Role of necroptosis in the pathogenesis of solid organ injury

Abstract

Necroptosis is a type of regulated cell death dependent on the activity of receptor-interacting serine/threonine-protein (RIP) kinases. However, unlike apoptosis, it is caspase independent. Increasing evidence has implicated necroptosis in the pathogenesis of disease, including ischemic injury, neurodegeneration, viral infection and many others. Key players of the necroptosis signalling pathway are now widely recognized as therapeutic targets. Necrostatins may be developed as potent inhibitors of necroptosis, targeting the activity of RIPK1. Necrostatin-1, the first generation of necrostatins, has been shown to confer potent protective effects in different animal models. This review will summarize novel insights into the involvement of necroptosis in specific injury of different organs, and the therapeutic platform that it provides for treatment.

DOI: 10.1038/cddis.2015.316
020406020162017
Citations per Year

Citation Velocity: 13

Averaging 13 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Zhao2015RoleON, title={Role of necroptosis in the pathogenesis of solid organ injury}, author={Hong Zhao and Tanweer Jaffer and Shiori Eguchi and Zheng Wang and Andreas Linkermann and D Ma}, journal={Cell Death and Disease}, year={2015}, volume={6}, pages={e1975-} }